<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Fifty 1 Labs, Inc. — News on 6ix</title>
<link>https://6ix.com/company/fifty-1-labs-inc</link>
<description>Latest news and press releases for Fifty 1 Labs, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 15 Apr 2026 12:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/fifty-1-labs-inc" rel="self" type="application/rss+xml" />
<item>
<title>Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-accelerates-peptide-biotechnology-push-into-musculoskeletal-health</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-accelerates-peptide-biotechnology-push-into-musculoskeletal-health</guid>
<pubDate>Wed, 15 Apr 2026 12:30:00 GMT</pubDate>
<description>Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health.</description>
</item>
<item>
<title>Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-eliminates-612-million-shares-from-the-market</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-eliminates-612-million-shares-from-the-market</guid>
<pubDate>Tue, 14 Apr 2026 12:30:00 GMT</pubDate>
<description>Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market.</description>
</item>
<item>
<title>Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty1-labs-inc-clarifies-status-regarding-previously-announced-collaboration-with-lunr-aerospace</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty1-labs-inc-clarifies-status-regarding-previously-announced-collaboration-with-lunr-aerospace</guid>
<pubDate>Mon, 05 Jan 2026 18:08:00 GMT</pubDate>
<description>Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace.</description>
</item>
<item>
<title>Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-appoints-dr-joel-gagnier-as-chief-science-officer</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-appoints-dr-joel-gagnier-as-chief-science-officer</guid>
<pubDate>Thu, 09 Oct 2025 14:23:00 GMT</pubDate>
<description>Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer.</description>
</item>
<item>
<title>Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc.</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-signs-letter-of-intent-to-acquire-biospark-ai-technologies-inc</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-signs-letter-of-intent-to-acquire-biospark-ai-technologies-inc</guid>
<pubDate>Tue, 30 Sep 2025 13:56:00 GMT</pubDate>
<description>Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc..</description>
</item>
<item>
<title>Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-engages-pcaob-auditing-firm-to-prepare-for-uplist-to-otcqb</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-engages-pcaob-auditing-firm-to-prepare-for-uplist-to-otcqb</guid>
<pubDate>Tue, 23 Sep 2025 13:07:00 GMT</pubDate>
<description>Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB.</description>
</item>
<item>
<title>Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty1-labs-inc-leadership-publishes-landmark-framework-to-unlock-global-oncology-data-through-ai-driven-real-world-evidence</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty1-labs-inc-leadership-publishes-landmark-framework-to-unlock-global-oncology-data-through-ai-driven-real-world-evidence</guid>
<pubDate>Thu, 04 Sep 2025 12:30:00 GMT</pubDate>
<description>Leadership Team's Technical Primer Enhances Real-World Evidence (RWE) for Cross-Border Impact, Positioning Fifty1 AI Labs in a $48B Market OpportunityVANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN – Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY), announces the publication of a landmark technical primer on "transportability" methods in oncology real-world evidence (RWE). Authored by CTO Alind Gupta and CEO Paul Arora, the primer, published in the Journal of</description>
</item>
<item>
<title>Fifty1 Labs Partners with LUNR Aerospace to Pioneer AI-Driven Drug Repurposing for Space Medicine, Strategic Collaboration Aims to Harness AI and Orbital Access to Revolutionize Astronaut Health Solutions in a $2 Billion Market by 2032</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty1-labs-partners-with-lunr-aerospace-to-pioneer-ai-driven-drug-repurposing-for-space-medicine-strategic-collaboration-aims-to-harness-ai-and-orbital-access-to-revolutionize-astronaut-health-solutions-in-a-dollar2-billion-market-by-2032</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty1-labs-partners-with-lunr-aerospace-to-pioneer-ai-driven-drug-repurposing-for-space-medicine-strategic-collaboration-aims-to-harness-ai-and-orbital-access-to-revolutionize-astronaut-health-solutions-in-a-dollar2-billion-market-by-2032</guid>
<pubDate>Tue, 26 Aug 2025 13:18:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 AI Labs, a subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), has entered a groundbreaking partnership with LUNR Aerospace to develop AI-driven drug repurposing initiatives tailored for space medicine. This collaboration targets critical health challenges in microgravity, including immune support, musculoskeletal resilience, neuro-ocular protection (Spaceflight-Associated Neuro-Ocular Syndrome, or SANS), cardiovascular</description>
</item>
<item>
<title>Fifty1 Labs, Inc. Subsidiary Fifty1 AI Labs Partners with ViRx@Stanford Under 'BE READI!' Initiative to Advance AI-Powered Antiviral Drug Repurposing</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty1-labs-inc-subsidiary-fifty1-ai-labs-partners-with-virxstanford-under-be-readi-initiative-to-advance-ai-powered-antiviral-drug-repurposing</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty1-labs-inc-subsidiary-fifty1-ai-labs-partners-with-virxstanford-under-be-readi-initiative-to-advance-ai-powered-antiviral-drug-repurposing</guid>
<pubDate>Fri, 22 Aug 2025 14:30:00 GMT</pubDate>
<description>Fifty1 Labs, Inc. Subsidiary Fifty1 AI Labs Partners with ViRx@Stanford Under 'BE READI!' Initiative to Advance AI-Powered Antiviral Drug Repurposing.</description>
</item>
<item>
<title>Fifty 1 Labs, Inc. and The Gates Foundation Lead Largest-Ever Sickle Cell Disease Study, Unlocking Pathways for Gene-Based and Repurposed Therapies</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-and-the-gates-foundation-lead-largest-ever-sickle-cell-disease-study-unlocking-pathways-for-gene-based-and-repurposed-therapies</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-and-the-gates-foundation-lead-largest-ever-sickle-cell-disease-study-unlocking-pathways-for-gene-based-and-repurposed-therapies</guid>
<pubDate>Thu, 14 Aug 2025 12:30:00 GMT</pubDate>
<description>Fifty 1 Labs, Inc. and The Gates Foundation Lead Largest-Ever Sickle Cell Disease Study, Unlocking Pathways for Gene-Based and Repurposed Therapies.</description>
</item>
<item>
<title>Fifty1 Labs, Inc. and BioSpark AI Unlock 2,000+ Real-World Treatment Pathways to Accelerate Functional Medicine Innovation</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty1-labs-inc-and-biospark-ai-unlock-2000-real-world-treatment-pathways-to-accelerate-functional-medicine-innovation</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty1-labs-inc-and-biospark-ai-unlock-2000-real-world-treatment-pathways-to-accelerate-functional-medicine-innovation</guid>
<pubDate>Tue, 12 Aug 2025 12:30:00 GMT</pubDate>
<description>Fifty1 Labs, Inc. and BioSpark AI Unlock 2,000+ Real-World Treatment Pathways to Accelerate Functional Medicine Innovation.</description>
</item>
<item>
<title>Fifty 1 Labs, Inc. Hosts Successful Virtual Shareholder Teleconference, Showcasing AI-Driven Functional Medicine Strategy and World-Class Leadership</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-hosts-successful-virtual-shareholder-teleconference-showcasing-ai-driven-functional-medicine-strategy-and-world-class-leadership</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-hosts-successful-virtual-shareholder-teleconference-showcasing-ai-driven-functional-medicine-strategy-and-world-class-leadership</guid>
<pubDate>Tue, 29 Jul 2025 13:00:00 GMT</pubDate>
<description>Fifty 1 Labs, Inc. Hosts Successful Virtual Shareholder Teleconference, Showcasing AI-Driven Functional Medicine Strategy and World-Class Leadership.</description>
</item>
<item>
<title>Fifty 1 Labs, Inc. to Host Virtual Shareholder Teleconference Featuring World-Class Leadership Team, including Dr. James Orbinski, who received the Nobel Peace Prize on Behalf of Médecins Sans Frontières</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-to-host-virtual-shareholder-teleconference-featuring-world-class-leadership-team-including-dr-james-orbinski-who-received-the-nobel-peace-prize-on-behalf-of-medecins-sans-frontieres</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-to-host-virtual-shareholder-teleconference-featuring-world-class-leadership-team-including-dr-james-orbinski-who-received-the-nobel-peace-prize-on-behalf-of-medecins-sans-frontieres</guid>
<pubDate>Mon, 28 Jul 2025 12:30:00 GMT</pubDate>
<description>Fifty 1 Labs, Inc. to Host Virtual Shareholder Teleconference Featuring World-Class Leadership Team, including Dr. James Orbinski, who received the Nobel Peace Prize on Behalf of Médecins Sans Frontières.</description>
</item>
<item>
<title>Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-fity-sparks-ai-breakthrough-in-drug-repurposing-subsidiary-fifty1-ai-labs-announces-strategic-partnership-with-intent-to-acquire-biospark-ai-technologies</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-fity-sparks-ai-breakthrough-in-drug-repurposing-subsidiary-fifty1-ai-labs-announces-strategic-partnership-with-intent-to-acquire-biospark-ai-technologies</guid>
<pubDate>Thu, 17 Jul 2025 12:55:00 GMT</pubDate>
<description>Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies.</description>
</item>
<item>
<title>Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty1-ai-labs-revive-clinical-trial-redefines-long-covid-treatment-pioneering-ai-driven-therapies-and-propelling-fifty-1-labs-inc-toward-dollar50m-valuation-and-global-biotech-leadership</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty1-ai-labs-revive-clinical-trial-redefines-long-covid-treatment-pioneering-ai-driven-therapies-and-propelling-fifty-1-labs-inc-toward-dollar50m-valuation-and-global-biotech-leadership</guid>
<pubDate>Thu, 10 Jul 2025 12:56:00 GMT</pubDate>
<description>Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership.</description>
</item>
<item>
<title>Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-announces-bold-expansion-plan-powered-by-nobel-prize-laureate-management-team-cutting-edge-ai-healthcare-innovation-and-dollar350k-leadership-investment</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-announces-bold-expansion-plan-powered-by-nobel-prize-laureate-management-team-cutting-edge-ai-healthcare-innovation-and-dollar350k-leadership-investment</guid>
<pubDate>Tue, 08 Jul 2025 12:30:00 GMT</pubDate>
<description>Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment.</description>
</item>
<item>
<title>Fifty 1 Labs, Inc. Accelerates Growth with New CEO, BioSentry Division Launch and Shareholder Dividend; Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-accelerates-growth-with-new-ceo-biosentry-division-launch-and-shareholder-dividend-company-pursues-strategic-growth-through-uav-partnership-and-targeted-acquisitions-in-advanced-tech-and-wellness</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/fifty-1-labs-inc-accelerates-growth-with-new-ceo-biosentry-division-launch-and-shareholder-dividend-company-pursues-strategic-growth-through-uav-partnership-and-targeted-acquisitions-in-advanced-tech-and-wellness</guid>
<pubDate>Wed, 30 Apr 2025 13:07:00 GMT</pubDate>
<description>Fifty 1 Labs, Inc. Accelerates Growth with New CEO, BioSentry Division Launch and Shareholder Dividend; Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness.</description>
</item>
<item>
<title>UAV Corp. Drives Growth with Partnership, Dividend, New Leadership, and DART SA-70 Test Success</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/uav-corp-drives-growth-with-partnership-dividend-new-leadership-and-dart-sa-70-test-success</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/uav-corp-drives-growth-with-partnership-dividend-new-leadership-and-dart-sa-70-test-success</guid>
<pubDate>Wed, 30 Apr 2025 12:30:00 GMT</pubDate>
<description>UAV Corp. Drives Growth with Partnership, Dividend, New Leadership, and DART SA-70 Test Success.</description>
</item>
<item>
<title>UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology, Genetic Networks Signs MOU with UMAV</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/uav-corp-and-genetic-networks-announce-strategic-collaboration-to-combat-biohazards-with-cutting-edge-technology-genetic-networks-signs-mou-with-umav</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/uav-corp-and-genetic-networks-announce-strategic-collaboration-to-combat-biohazards-with-cutting-edge-technology-genetic-networks-signs-mou-with-umav</guid>
<pubDate>Wed, 09 Apr 2025 13:03:09 GMT</pubDate>
<description>UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology, Genetic Networks Signs MOU with UMAV.</description>
</item>
<item>
<title>UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology</title>
<link>https://6ix.com/company/fifty-1-labs-inc/news/uav-corp-and-genetic-networks-announce-strategic-collaboration-to-combat-biohazards-with-cutting-edge-technology</link>
<guid isPermaLink="true">https://6ix.com/company/fifty-1-labs-inc/news/uav-corp-and-genetic-networks-announce-strategic-collaboration-to-combat-biohazards-with-cutting-edge-technology</guid>
<pubDate>Tue, 08 Apr 2025 12:31:23 GMT</pubDate>
<description>UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology.</description>
</item>
</channel>
</rss>